J Korean Thyroid Assoc.  2011 May;4(1):54-57.

A Case of Agranulocytosis and Soft Tissue Abscess after Increasing Methimazole Dose in a Patient with Graves Disease under Long-term Mainternance Therapy

• Park SY
• Chun SW
• Kim YJ
• Kim SJ

Abstract

Antithyroid drugs (ATD) has been widely used to treat Graves' disease. However agranulocytosis, a serious fatal complication of ATD treatment, occurs in about 0.5 percent. The symptoms may mimic viral infections (fever, sore throat), and the potentially life-threatening pyogenic infections can go unrecognized initially. The median duration of drug exposure before the onset of acute agranulocytosis is within 30 days in most cases. We report a case of agranulocytosis with secondary soft tissue infection and abscess occuring after increasing the dose of methimazole in a woman who had taken methimazole for more than 10 years. We administered broad-spectrum antibiotics and aspirated the soft tissue abscess. A review of the medical literature regarding agranulocytosis in the setting of ATDs is presented.

Keyword

Agranulocytosis; Graves' disease; Soft tissue infections

MeSH Terms

Abscess
Agranulocytosis
Anti-Bacterial Agents
Antithyroid Agents
Female
Graves Disease
Humans
Hydrazines
Methimazole
Soft Tissue Infections
Anti-Bacterial Agents
Antithyroid Agents
Hydrazines
Methimazole